Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon R W Stott

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Practical Neurology|January 7, 2015
The wrong James ParkinsonSimon R W Stott
The European Journal of Neuroscience|October 28, 2006
Targeted in utero delivery of a retroviral vector for gene transfer in the rodent brainSimon R W Stott, Deniz Kirik
The European Journal of Neuroscience|December 31, 2013
Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's diseaseSimon R W Stott, Roger A Barker
Frontiers in Neuroscience|April 5, 2021
Drug Repurposing for Parkinson's Disease: The International Linked Clinical Trials experienceSimon R W Stott, Richard K Wyse, Patrik Brundin
Progress in Brain Research|April 6, 2020
Novel approaches to counter protein aggregation pathology in Parkinson's diseaseSimon R W Stott, Richard K Wyse, Patrik Brundin
Experimental Neurology|January 10, 2013
Stem cells and the treatment of Parkinson's diseaseFahad Ali, Simon R W Stott, Roger A Barker
Blood|December 17, 2008
Polyclonal T-cell reconstitution of X-SCID recipients after in utero transplantation of lymphoid-primed multipotent progenitorsKarina Liuba, Cornelis J H Pronk, Simon R W Stott, et al.
Journal of Parkinson'S Disease|June 21, 2021
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2021 UpdateKevin McFarthing, Gary Rafaloff, Marco A S Baptista, et al.
Journal of Parkinson'S Disease|August 4, 2020
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020Kevin McFarthing, Sue Buff, Gary Rafaloff, et al.
Plos One|February 10, 2017
CD24 expression does not affect dopamine neuronal survival in a mouse model of Parkinson's diseaseSimon R W Stott, Shaista Hayat, Tom Carnwath, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Practical Neurology|January 7, 2015
The wrong James ParkinsonSimon R W Stott
The European Journal of Neuroscience|October 28, 2006
Targeted in utero delivery of a retroviral vector for gene transfer in the rodent brainSimon R W Stott, Deniz Kirik
The European Journal of Neuroscience|December 31, 2013
Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's diseaseSimon R W Stott, Roger A Barker
Frontiers in Neuroscience|April 5, 2021
Drug Repurposing for Parkinson's Disease: The International Linked Clinical Trials experienceSimon R W Stott, Richard K Wyse, Patrik Brundin
Progress in Brain Research|April 6, 2020
Novel approaches to counter protein aggregation pathology in Parkinson's diseaseSimon R W Stott, Richard K Wyse, Patrik Brundin
Experimental Neurology|January 10, 2013
Stem cells and the treatment of Parkinson's diseaseFahad Ali, Simon R W Stott, Roger A Barker
Blood|December 17, 2008
Polyclonal T-cell reconstitution of X-SCID recipients after in utero transplantation of lymphoid-primed multipotent progenitorsKarina Liuba, Cornelis J H Pronk, Simon R W Stott, et al.
Journal of Parkinson'S Disease|June 21, 2021
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2021 UpdateKevin McFarthing, Gary Rafaloff, Marco A S Baptista, et al.
Journal of Parkinson'S Disease|August 4, 2020
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020Kevin McFarthing, Sue Buff, Gary Rafaloff, et al.
Plos One|February 10, 2017
CD24 expression does not affect dopamine neuronal survival in a mouse model of Parkinson's diseaseSimon R W Stott, Shaista Hayat, Tom Carnwath, et al.
Pageof 3